BVS vs CFLT · rev $573.3M vs rev $963.6M
Bioventus Inc (BVS) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BVS currently screens at market cap $495.1M. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BVS and CFLT stock pages for the full models.
Not investment advice.